INFORMATIVE SITE.

remdesivir tablet Remdesivir is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. As of  2020, remdesivir is under investigation as a specific treatment for COVID-19 and has been authorized by the U.S. Food and Drug Administration (FDA) under Emergency Use Authorization (EUA) for emergency treatment for those hospitalized with severe disease. It may have an effect on the time it takes to recover from the disease. It is given by injection into a vein. SECTIONS Dosing & Uses ADULT PEDIATRIC Dosage Forms & Strengths injection, lyophilized powder for reconstitution 100mg/vial injection, solution 100mg/20mL (5mg/mL) Coronavirus Disease 2019 (COVID-19) (Investigational) May 1, 2020: The FDA has granted an emergency use authorization (EUA) for remdesivir to treat hospitalized adults and children with suspected or laboratory-confirmed SARS CoV-2 infection and severe COVID-19 disease EUA facilitates broader use of remdesivir,

The FDA has granted an emergency use authorization (EUA) for remdesivir to treat hospitalized adults and children with suspected or laboratory-confirmed SARS CoV-2 infection and severe COVID-19 disease EUA facilitates broader use of remdesivir, enabling access at additional hospitals across the country Severe COVID-19 disease is defined as patients with an oxygen saturation (SpO2) ≤94% on room air or requiring supplemental oxygen or requiring mechanical ventilation or requiring extracorporeal membrane oxygenation (ECMO) An experimental drug — and one of the world’s best hopes for treating COVID-19 — could shorten the time to recovery from coronavirus infection, according to the largest and most rigorous clinical trial of the compound yet. The drug, called remdesivir, interferes with the replication of some viruses, including SARS-CoV-2, which is responsible for the current pandemic. On 29 April, Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases (NI